<DOC>
	<DOCNO>NCT00952237</DOCNO>
	<brief_summary>We postulate combination IL-2 GM-CSF immunotherapy efficiently mobilize autologous peripheral blood stem cell activate immune effector cell patient hematologic malignancy . These activated effector cell improve immune function graft . These hypothesis test use propose clinical trial mobilize autologous peripheral blood stem cell pre-transplantation .</brief_summary>
	<brief_title>Immune Mobilization Autologous Peripheral Blood Stem Cells Using Interleukin-2 GM-CSF</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Paraproteinemias</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>All patient must pathologic diagnosis one follow malignancy : NonHodgkin 's Lymphoma , Hodgkin 's Disease , Multiple Myeloma plasma cell dyscrasia ( Waldenstrom , Amyloidosis ) , Leukemia ( AML , ALL , CLL ) Prior Treatment : &gt; 2 week prior initiation therapy . Performance Status : Karnofsky &gt; 70 % Age &gt; 18 Life Expectancy &gt; 4 month Bone Marrow : bone marrow biopsy aspirate Blood count : The patient must adequate bone marrow function , i.e . total WBC &gt; 2,000/ul , Hgb &gt; 7 mg/dl , platelet count &gt; 50,000/ul , unless abnormality believe due underlying disease . Pulmonary function test : DLCO &gt; 55 % predict . Cardiac : Left ventricular ejection fraction &gt; 40 % radionuclide scan echocardiography . Liver function test ( bilirubin , alkaline phosphatase , SGOT/SGPT ) &lt; 3 x normal ( unless believe elevate due disease ) . No significant comorbid medical psychiatric illness would significantly compromise patient 's clinical care chance survival . Informed Consent : Informed consent must sign prior treatment . Patients must aware neoplastic nature disease willingly consent informed procedure follow , nature therapy , alternative , potential benefit , side effect , risk discomfort . The patient deem eligible serious medical psychiatric illness would prevent informed consent . ( Human protection committee approval protocol consent form require . ) Medical , social , psychological factor would prevent patient receive cooperate full course therapy . Evidence physical exam , LP , CT , MRI scan CNS involvement malignancy . Uncontrolled severe cardiovascular disease , include recent ( &lt; 6 month ) myocardial infarction , congestive heart failure , angina ( symptomatic despite optimal medical management ) , lifethreatening arrhythmia , hypertension clinically significant obstructive/restrictive pulmonary disease . Serology positive HIV History seizure . Concurrent expect need therapy systemic corticosteroid ( since systemic steroid may suppress effect IL2 ) . Current clinically significant pleural effusion , pericardial effusion , ascites . Positive pregnancy test presence lactation . Uncontrolled active infection . Documented hypersensitivity drug use protocol . No concomitant , ongoing malignancy lifethreatening , base PI 's evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Autologous Peripheral Blood Stem Cell Transplant</keyword>
	<keyword>IL-2</keyword>
	<keyword>GM-CSF</keyword>
</DOC>